Trending...
- Countryside Golf & Country Club general manager receives prestigious professional designation
- Better Together receives $15,000 from Gulf Coast Community Foundation to support hurricane relief
- The World's No.1 Superstar Is Celebrating His 21st Birthday for the 28th Time Today!
CAMBRIDGE, Mass., Nov. 26, 2024 /PRNewswire/ -- Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced that Peter Smith, Ph.D., Co-Founder and Chief Executive Officer of Remix, will present a corporate overview at the 7th Annual Evercore HealthCONx Conference in Miami on Tuesday, December 3, 2024, at 3:25 p.m. ET.
For investors interested in scheduling a one-on-one meeting with the Remix management team, please contact your Evercore representative.
About Remix Therapeutics
Remix Therapeutics is a clinical-stage biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and treat disease. The REMaster™ technology platform facilitates RNA processing pattern identification, leveraging these learnings to modulate gene expression. Remix's innovative therapeutic approach has the potential to alter the way genes are read from the genome, to correct, enhance, or eliminate the gene message, thereby addressing disease drivers at their origin. For more information visit www.remixtx.com.
More on The Floridant
Contacts:
Media Contact:
Peg Rusconi
Deerfield Group
[email protected]
Investor Contact:
Will O'Connor
Precision AQ
[email protected]
SOURCE Remix Therapeutics
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
GET STARTED
For investors interested in scheduling a one-on-one meeting with the Remix management team, please contact your Evercore representative.
About Remix Therapeutics
Remix Therapeutics is a clinical-stage biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and treat disease. The REMaster™ technology platform facilitates RNA processing pattern identification, leveraging these learnings to modulate gene expression. Remix's innovative therapeutic approach has the potential to alter the way genes are read from the genome, to correct, enhance, or eliminate the gene message, thereby addressing disease drivers at their origin. For more information visit www.remixtx.com.
More on The Floridant
- Naughty Nevada Band Launches a Bold New Website Design
- Inspiring the Full Arch Industry: Dr. James Fetsch Speaks At The Full Arch Growth Conference 2024
- BHRT Training Academy Announces inaugural BHRT 'Symposium at Sea 2025' for Healthcare Providers
- 3Li: Revolutionizing Lithium Trading with Blockchain Technology
- The Score Album for "The Lost Weekend: A Love Story" Released Today
Contacts:
Media Contact:
Peg Rusconi
Deerfield Group
[email protected]
Investor Contact:
Will O'Connor
Precision AQ
[email protected]
SOURCE Remix Therapeutics
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
GET STARTED
Filed Under: Business
0 Comments
Latest on The Floridant
- Christmas comes early as Shop with a Sheriff makes holiday season brighter for Naples families
- Shape the Future of OpenSSL: Election Period Open Now!
- LIB Empowers Uzbekistan's Automotive Industry: A New Era of Quality Assurance
- Nader Sculpture Park Officially Opens in Miami Design District During Miami Art Week
- Delray Beach's Grounded Visions Launches Integral Eye Movement Therapy
- TijaraIQ.com Launches as Iraq's Free Marketplace for Buying, Selling, and Creating Opportunities
- Big News!! Best Sac Homes Group Partners with LPT Realty
- Juventix Regenerative Medical PRP Highlighted in University-Published Research Study
- Blue Point USA LLC Secures GSA Multiple Award Schedule Contract with Assistance from Government Marketplace LLC
- Klime Kovaceski Enlists Dimi De San for Captivating Track Odyssey on His 14th Album Release in Less
- Dale Sorensen Real Estate Names Donna Browning Vice President of Sales, Announcing Her Return to the Company
- SmallPC Launches Redesigned Website, Announces Partnership with Cincoze, & Expands Product Offering
- Dr. Barrie Matthews of Big Sky Smile Center Speaks at the Full Arch Growth Conference, Inspiring Dentists Nationwide
- The Florida Forum Speaker Series to Welcome Deepak Chopra
- Tommy Bohanon Foundation collects 600 toys, raises $20,000 at 2024 Softball Tournament
- Project Astral NFT Drop by AI Film Guerrillas Released via Ethereum on Base Network
- Dr. Sathish Palayam Speaks at the Full Arch Growth Conference, Sharing Insights to Revolutionize Patient Care!
- InStockRx Wins 1871 Supply Chain Pitch, Announces GS1 Partnership
- Donors and Recipients of Nashville Chopin's Metro School Piano Donation Program Announced
- WPB's Mounts Botanical Garden is Offering Two Special Yuletide Events This Month